The BIG Move to EHR Part II

On the contrary to my last blog, a Deloitte survey has found that 75% of doctors say electronic heal... | read full article

What is Macular Degeneration?

Macular degeneration is damage of the central part of the retina, called the macula, which helps us ... | read full article

The BIG Move to EHR

The Wall Street Journal recently reported that a new study shows that a hospital group was able to r... | read full article

read more news stories


Monday, November 03, 2014, 06:45 PM to 09:00 PM

Cynthia Matossian, MD, FACS and Henry Lee, MD will be hosting a COPE credit event at the Brick Hotel... | read full article

Wednesday, November 05, 2014, 10:30 AM to 01:00 PM

Dan Rue will be providing students at Mercer County Community College with free vision screenings at... | read full article

Wednesday, November 05, 2014, 02:30 PM to 04:00 PM

Cynthia Matossian, MD, FACS will be speaking about creating a Dry Eye Center of Excellence for a gro... | read full article

read more events stories


What Ever Happened to Dilation Reversal Drops?

Posted on: Thursday, September 29, 2011
Author: Matossian Eye Associates

Tags: eye exam, dialation, dapiprazole, pupil constriction

Pupillary dilation is a crutial part of your eye exam, and a most valuable step toward protecting your eye health.  But it is also greatly disliked by most patients.  Dilation drops typically take 4-6 hours to wear off, and during that time blurred vision and light sensitivity remain.  Released in 1991, Rev-Eyes (dapiprazole), promised to revolutionize the practice of eye care by providing a means to reverse dilation.  The new drop counteracted dilation by stimulating pupil constriction.  The reality of the situation was that the drop tended to work slow, often taking a few hours to return pupils to their normal state.  The drop also caused unpleasant side effects such as stinging upon instillation and red eyes in the majority of patients.  It was also expensive, costing 4-5x more than the dilation drops.  Rev-Eyes are no longer available in the United States, but hope remains for an alternative.   
Rebecca Mueller, O.D.



Blog Home